| # | Drug | Count |
|---|---|---|
| 0 | ACETAMINOPHEN | 5 |
| 1 | ACETAMINOPHEN 500MG | 5 |
| 2 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 5 |
| 3 | CERTOLIZUMAB PEGOL | 5 |
| 4 | PAIN RELIEVER | 5 |
| 5 | PREDNISONE | 5 |
| 6 | IBUPROFEN | 3 |
| 7 | ERGOCALCIFEROL | 2 |
| 8 | FUROSEMIDE | 2 |
| 9 | IBUPFROFEN | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PRUCALOPRIDE | 1 | 0.0004 |
| 1 | NADOLOL | 1 | 0.0001 |
| 2 | AMLODIPINE BESYLATE AND VALSARTAN | 1 | 0.0001 |
| 3 | ERGOCALCIFEROL | 2 | 0.0001 |
| 4 | EZETIMIBE AND SIMVASTATIN | 1 | 0.0001 |
| 5 | BENZONATATE | 1 | 0.0001 |
| 6 | VORTIOXETINE | 1 | 0.0001 |
| 7 | HUMAN IMMUNOGLOBULIN G | 1 | 0.0000 |
| 8 | LURASIDONE HYDROCHLORIDE | 1 | 0.0000 |
| 9 | BENRALIZUMAB | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 1 | Non-narcotic Antitussive [EPC] | 1 | 0.0001 |
| 2 | Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |
| 3 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 4 | Recombinant Human Growth Hormone [EPC] | 1 | 0.0000 |
| 5 | Epidermal Growth Factor Receptor Antagonist [EPC] | 1 | 0.0000 |
| 6 | Histamine-1 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 7 | Dietary Cholesterol Absorption Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Partial Opioid Agonist [EPC] | 1 | 0.0000 |
| 9 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 | 0.0000 |